Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce Y Lee

Showing results (31-40 of 275) with videos related to

Pageof 28
Sort By:
Plos Neglected Tropical Diseases|April 21, 2017
How to determine if a model is right for neglected tropical disease decision makingBruce Y Lee, Sarah M Bartsch
Vaccine|September 29, 2009
Constructing target product profiles (TPPs) to help vaccines overcome post-approval obstaclesBruce Y Lee, Donald S Burke
Vaccine|April 3, 2017
Immunization supply chains: Why they matter and how they are changingRaja Rao, Benjamin Schreiber, Bruce Y Lee
JAMA|December 11, 2003
Lifestyle as a factor in medical students' career choicesBruce Y Lee, Todd Hecht, Kevin Volpp
Pathogens and Global Health|January 13, 2015
The cost of an Ebola caseSarah M Bartsch, Katrin Gorham, Bruce Y Lee
Archives of Internal Medicine|August 11, 2010
Ambulatory antibiotic use and prescription drug coverage in older adultsYuting Zhang, Bruce Y Lee, Julie M Donohue
JAMA|January 20, 2005
Regionalization of coronary angioplasty and travel distanceBruce Y Lee, Anand Shah, Esther H Chen
Health Affairs (Project Hope)|August 9, 2017
Modeling Children's Activity: The Authors ReplyBruce Y Lee, Marie C Ferguson, Atif Adam
Advances in Parasitology|March 14, 2015
Economic and financial evaluation of neglected tropical diseasesBruce Y Lee, Sarah M Bartsch, Katrin M Gorham
The American Journal of Tropical Medicine and Hygiene|July 9, 2014
The impact of human immunodeficiency virus (HIV) co-infection on the economic burden of cutaneous leishmaniasis (CL) in Brazil and potential value of new CL drug treatmentsStephanie D Kruchten, Kristina M Bacon, Bruce Y Lee
Pageof 28

Showing results (31-40 of 275) with videos related to

Sort By:
Pageof 28
Plos Neglected Tropical Diseases|April 21, 2017
How to determine if a model is right for neglected tropical disease decision makingBruce Y Lee, Sarah M Bartsch
Vaccine|September 29, 2009
Constructing target product profiles (TPPs) to help vaccines overcome post-approval obstaclesBruce Y Lee, Donald S Burke
Vaccine|April 3, 2017
Immunization supply chains: Why they matter and how they are changingRaja Rao, Benjamin Schreiber, Bruce Y Lee
JAMA|December 11, 2003
Lifestyle as a factor in medical students' career choicesBruce Y Lee, Todd Hecht, Kevin Volpp
Pathogens and Global Health|January 13, 2015
The cost of an Ebola caseSarah M Bartsch, Katrin Gorham, Bruce Y Lee
Archives of Internal Medicine|August 11, 2010
Ambulatory antibiotic use and prescription drug coverage in older adultsYuting Zhang, Bruce Y Lee, Julie M Donohue
JAMA|January 20, 2005
Regionalization of coronary angioplasty and travel distanceBruce Y Lee, Anand Shah, Esther H Chen
Health Affairs (Project Hope)|August 9, 2017
Modeling Children's Activity: The Authors ReplyBruce Y Lee, Marie C Ferguson, Atif Adam
Advances in Parasitology|March 14, 2015
Economic and financial evaluation of neglected tropical diseasesBruce Y Lee, Sarah M Bartsch, Katrin M Gorham
The American Journal of Tropical Medicine and Hygiene|July 9, 2014
The impact of human immunodeficiency virus (HIV) co-infection on the economic burden of cutaneous leishmaniasis (CL) in Brazil and potential value of new CL drug treatmentsStephanie D Kruchten, Kristina M Bacon, Bruce Y Lee
Pageof 28